Denka Co Ltd
TSE:4061

Watchlist Manager
Denka Co Ltd Logo
Denka Co Ltd
TSE:4061
Watchlist
Price: 3 680 JPY -2.67% Market Closed
Market Cap: ¥325.9B

Denka Co Ltd
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Denka Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Denka Co Ltd
TSE:4061
Note Receivable
¥1.1B
CAGR 3-Years
99%
CAGR 5-Years
N/A
CAGR 10-Years
-3%
Asahi Kasei Corp
TSE:3407
Note Receivable
¥10.3B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Kuraray Co Ltd
TSE:3405
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Toray Industries Inc
TSE:3402
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mitsui Chemicals Inc
TSE:4183
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Tosoh Corp
TSE:4042
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Denka Co Ltd
Glance View

Market Cap
325.9B JPY
Industry
Chemicals

Denka Co., Ltd. is a fascinating player weaving its intricate narrative into the fabric of the industrial world, rooted in innovation and diversification. Founded in 1915, Denka has evolved from a pioneer in the realm of carbide chemistry to a dynamic force in advanced materials. Today's Denka is a multi-faceted conglomerate operating in several key industries, including chemicals, electronics, healthcare, and infrastructure. The company’s strategy revolves around leveraging its chemical expertise to create high-performance materials. These range from functional elastomers and resins to specialty fertilizers and cement additives. The essence of Denka’s business model lies in turning scientific breakthroughs into practical solutions that enhance everyday life, making its products indispensable across a broad spectrum of industries. The company's ability to generate revenue is tightly linked to its commitment to research and development. By continually refining their production processes, Denka ensures their products remain at the cutting edge of performance and sustainability. In the healthcare sector, Denka has made strides with its influenza vaccine, leveraging its pharmaceutical know-how to meet growing global health demands. Meanwhile, its conductive materials are critical in the burgeoning electronics and electric vehicle markets, meeting the demand for more efficient, eco-friendly components. Denka’s financial well-being is further strengthened by its extensive global network, which allows it to tap into diverse markets, offsetting the volatility inherent in any single industry. Through strategic partnerships and a robust value chain, Denka continues to position itself at the confluence of tradition and innovation, shaping a sustainable future for itself and its clientele.

Intrinsic Value
2 861.29 JPY
Overvaluation 22%
Intrinsic Value
Price ¥3 680

See Also

What is Denka Co Ltd's Note Receivable?
Note Receivable
1.1B JPY

Based on the financial report for Dec 31, 2025, Denka Co Ltd's Note Receivable amounts to 1.1B JPY.

What is Denka Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
-3%

Over the last year, the Note Receivable growth was 1 018%. The average annual Note Receivable growth rates for Denka Co Ltd have been 99% over the past three years , and -3% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett